Humana Inc. filed a Form 8-K with the SEC, reporting that senior management will meet with investors and analysts from March 3 to March 31, 2025. The company reaffirmed its guidance for the fiscal year 2025, projecting approximately $15.88 in diluted earnings per share (EPS) and $16.25 in adjusted EPS, consistent with prior guidance from February 11, 2025. Adjusted EPS, a non-GAAP measure, is used to analyze core business performance. The report includes a reconciliation of GAAP EPS to adjusted EPS, accounting for amortization and tax impacts. A cautionary statement notes that forward-looking statements are subject to risks and uncertainties as detailed in Humana’s SEC filings. The report is signed by John-Paul W. Felter, Senior Vice President, Chief Accounting Officer & Controller.